Background: In reviewing the laboratory studies on humans and animals, we observe that
use of certain drugs with specified applications inhibit the immune reactions in the body …

Coronavirus disease 2019 (COVID-19) has placed strain on the global health landscape. As
of July 19, 2021, this emerging infection had caused 188,655,968 infections and 4,067,517 …

Currently, there is not any specific effective antiviral treatment for COVID-19. Although most
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …

In March 2020 the world officially released its first approach to the coronaviral pandemic to
explain the rationale for using hydroxychloroquine. It was also believed to calm down the …

Abstract Purpose of Review The rapid spread of virus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency. Symptoms of this …

Coronavirus disease 2019 (Covid-19), leads to global calamitous effects. Covid-19 is
caused by a novel coronavirus named as severe acute respiratory syndrome coronavirus 2 …

The 2019 coronavirus infectious disease (COVID-19) is caused by infection with the new
severe acute respiratory syndrome coronavirus (SARS-CoV-2). Currently, the treatment …

No specific and effective anti-viral treatment has been approved for COVID-19 so far.
Systemic corticosteroid has been sometimes administered to severe infectious diseases …

Abstract Background: The UK COVID-19 infections in first and second waves were from the
alpha and delta variants and seen to be a life-threatening illness for high risk patients mainly …

Azithromycin, a member of the macrolide family of antibiotics, is commonly used to treat
respiratory bacterial infections. Nevertheless, multiple pharmacological effects of the drug …